{"result": {"id": "chatcmpl-BU4HBAz74sn6hXmhBuL5Iqn3e3O0e", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>FEMALE LIFE ASSURED<|>PERSON<|>A female life assured is an individual who is insured under the policy and whose biological child may benefit from the congenital abnormalities coverage.)\n##\n(\"entity\"<|>BIOLOGICAL CHILD<|>PERSON<|>A biological child of the female life assured is eligible for benefits related to congenital abnormalities and hospitalisation expenses.)\n##\n(\"entity\"<|>COVER START DATE<|>DATE<|>The Cover Start Date is the date from which the insurance coverage begins, relevant for determining eligibility for benefits.)\n##\n(\"relationship\"<|>FEMALE LIFE ASSURED<|>BIOLOGICAL CHILD<|>The biological child is directly related to the female life assured and is eligible for benefits under her policy<|>9)\n##\n(\"relationship\"<|>FEMALE LIFE ASSURED<|>CONGENITAL ABNORMALITIES<|>The female life assured's biological child can receive benefits for congenital abnormalities<|>8)\n##\n(\"relationship\"<|>COVER START DATE<|>CONGENITAL ABNORMALITIES<|>The Cover Start Date is crucial for determining the eligibility period for congenital abnormalities benefits<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1746505977, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_0392822090", "usage": {"completion_tokens": 256, "prompt_tokens": 2832, "total_tokens": 3088, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 2688}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,benefit,date,event,location]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,benefit,date,event,location\nText: To avoid any doubt, under this benefit, we do not pay expenses incurred for Cell Tissue and Gene \nTherapy Treatment relating to congenital abnormalities of the life assured.\nThese conditions must be first diagnosed by a Registered Medical Practitioner.\nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\nFor a female life assured’s biological child\nFor a female life assured’s biological child with congenital abnormalities, we pay for hospitalisation \nexpenses incurred, up to the limit as set out in the Benefits Schedule, for Medically Necessary \ntreatment relating to birth defects, including hereditary conditions and congenital sickness or \nabnormalities of the female life assured’s biological child during the first 24 months from the date of \nbirth of the child. We will also pay for any pre- or post-hospitalisation expenses incurred in relation to \nthe Congenital Abnormalities benefit.\nThese conditions must be first diagnosed by a Registered Medical Practitioner or symptoms first \nappear after 10 months from the Cover Start Date or date of reinstatement (if any).\nThis benefit only applies to a life assured who is female. \nWe pay the hospitalisation expenses, as set out in the Benefits Schedule, provided the female life \nassured's biological child does not have any insurance coverage for such expenses or receive any \nreimbursement for expenses incurred, from another source. \nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\n1.4.6.4 What do we pay for Psychiatric Treatment? \nWe pay for the medical expenses incurred, up to the limit as set out in the Benefits Schedule, if the \nlife assured receives inpatient psychiatric treatments.\nPayment for all eligible expenses incurred under the Psychiatric Treatment, including Short Stay Ward, \nshall be accumulated and paid up to the respective limit as set out in the Benefits Schedule.\nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\nWe will also pay for any pre- or post-hospitalisation expenses incurred in relation to inpatient \npsychiatric treatments.\n1.4.6.5 What do we pay for Short Stay Ward? \nWe pay for the cost of Short Stay Ward even if it does not result in Hospital Confinement of the life \nassured.If the life assured is hospitalised and is confined to more than one ward type during his hospitalisation, \nthe deductible applied is based\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>BENEFIT<|>Cell Tissue and Gene Therapy Treatment is a benefit that covers expenses related to congenital abnormalities of the life assured, subject to certain conditions and limits.)\n##\n(\"entity\"<|>REGISTERED MEDICAL PRACTITIONER<|>PERSON<|>A Registered Medical Practitioner is a qualified individual who diagnoses conditions related to the benefits provided.)\n##\n(\"entity\"<|>CONGENITAL ABNORMALITIES<|>BENEFIT<|>Congenital Abnormalities benefit covers hospitalisation expenses for a female life assured's biological child with congenital defects during the first 24 months from birth.)\n##\n(\"entity\"<|>HOSPITALISATION<|>BENEFIT<|>Hospitalisation benefit covers expenses incurred for medically necessary treatment, including psychiatric treatments and short stay ward costs.)\n##\n(\"entity\"<|>PSYCHIATRIC TREATMENT<|>BENEFIT<|>Psychiatric Treatment benefit covers medical expenses for inpatient psychiatric treatments, subject to limits set in the Benefits Schedule.)\n##\n(\"entity\"<|>SHORT STAY WARD<|>BENEFIT<|>Short Stay Ward benefit covers costs incurred even if the life assured is not confined to a hospital during their stay.)\n##\n(\"relationship\"<|>REGISTERED MEDICAL PRACTITIONER<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>A Registered Medical Practitioner is required to diagnose conditions for the Cell Tissue and Gene Therapy Treatment benefit<|>8)\n##\n(\"relationship\"<|>REGISTERED MEDICAL PRACTITIONER<|>CONGENITAL ABNORMALITIES<|>A Registered Medical Practitioner must diagnose congenital abnormalities for the benefit to apply<|>8)\n##\n(\"relationship\"<|>HOSPITALISATION<|>CONGENITAL ABNORMALITIES<|>Hospitalisation expenses are covered under the Congenital Abnormalities benefit<|>7)\n##\n(\"relationship\"<|>HOSPITALISATION<|>PSYCHIATRIC TREATMENT<|>Hospitalisation expenses are covered under the Psychiatric Treatment benefit<|>7)\n##\n(\"relationship\"<|>HOSPITALISATION<|>SHORT STAY WARD<|>Hospitalisation benefit includes costs for Short Stay Ward<|>7)\n##\n(\"relationship\"<|>CONGENITAL ABNORMALITIES<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>Congenital Abnormalities benefit is a specific application of the Cell Tissue and Gene Therapy Treatment<|>6)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}